Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Adam Bell
Adam Bell, Portsmouth, NH US
| Patent application number | Description | Published |
|---|---|---|
| 20110009571 | SYSTEMS AND METHODS FOR DELIVERY OF MATERIALS - Systems and methods for delivering release materials, for example drugs and other bioactive materials. Crystalline polymeric systems, referred to as CYC carriers, are associated with the release materials, through chemical bonding or through physical association. The crystallinity of the CYC carriers results from the presence of crystallizable side chains, for example long chain n-alkyl moieties, which results in relatively low and sharp melting temperatures. One class of CYC carriers, referred to as CYSC polymers, have a majority of the crystallizable side chains pendant from the polymer backbone. Another class of CYC carriers referred to as ECC polymers, have a majority of the crystallizable side chains attached to terminal units of the polymer backbone. The ECC polymers can for example be obtained by modification of PLGA polymers. The CYC carriers in another class of non-polymeric. Some CYC carriers, referred to as CYC assemblies, have enhanced crystallinity as a result of the physical association of crystallizable moieties which are present in different types of molecule, for example between a polymer containing crystallizable moieties and a monomer containing crystallizable moieties. For some uses, particularly the delivery of drugs, a bioerodable CYC carrier is preferably used. | 01-13-2011 |
Adam Bell, Germantown, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20090029914 | Albumin Fusion Proteins - The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention. | 01-29-2009 |
| 20110002888 | Albumin Fusion Proteins - The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention. | 01-06-2011 |
Adam Bell, Short Hills, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100319576 | PROCESS FOR PREPARING SCENTED CELLULOSICS - The present invention provides a process for optimizing the fragrance of a scented cellulosic. | 12-23-2010 |
Adam Bell US
| Patent application number | Description | Published |
|---|---|---|
| 20100291033 | Albumin Fusion Proteins - The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention. | 11-18-2010 |
Adam Bell, Oxford GB
| Patent application number | Description | Published |
|---|---|---|
| 20100210792 | DRUG DELIVERY - Formulations of drugs and crystalline side chain polymers to provide controlled and/or sustained release drug formulations. | 08-19-2010 |
Adam Bell, San Francisco, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080269105 | Delivery of drugs - Formulations of drugs and crystalline side chain polymers to provide controlled and/or sustained release drug formulations. | 10-30-2008 |
| 20090263346 | Systems and methods for delivery of drugs - Systems and methods for delivering drugs. Crystalline polymeric systems, referred to as CYC carriers, are associated with the drugs, through chemical bonding or through physical association. The crystallinity of the CYC carriers results from the presence of crystallizable side chains, for example long chain n-alkyl moieties, which results in relatively low and sharp melting temperatures. One class of CYC carriers, referred to as CYSC polymers, have a majority of the crystallizable side chains pendant from the polymer backbone. Another class of CYC carriers, referred to as ECC polymers, have a majority of the crystallizable side chains attached to terminal units of the polymer backbone. The ECC polymers can for example be obtained by modification of PLGA polymers. The CYC carriers in another class are non-polymeric. Some CYC carriers, referred to as CYC assemblies, have enhanced crystallinity as a result of the physical association of crystallizable moieties which are present in different types of molecule, for example between a polymer containing crystallizable moieties and a monomer containing crystallizable moieties. Preferably the CYC carrier is bioerodable. | 10-22-2009 |
Adam Bell, Pacifica, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090209558 | Polymer formulations for delivery of bioactive materials - Delivery of drugs in association with PLGA polymers which have crystallinity resulting from the presence of long chain alkyl groups in terminal units. | 08-20-2009 |
| 20090252777 | Method for formulating a controlled-release pharmaceutical formulation - Methods for making formulations of drugs and crystalline side chain polymers which formulations provide controlled and/or sustained release drug formulations. | 10-08-2009 |
Adam Bell, Ottawa CA
| Patent application number | Description | Published |
|---|---|---|
| 20120046867 | Portable System for Analyzing and Determining Elemental Composition of Rock Samples - A portable system for elemental analysis includes one or more neutron emitters, a chamber for containing a test sample, at least one gamma ray detector electrically connected to a data acquisition system, and software or firmware executing on the data acquisition system from a non-transitory physical medium, the software or firmware providing a first function for producing one or more gamma ray spectrums, a second function for applying correction factors to the one or more gamma ray spectrums, and a third function for analyzing the corrected gamma ray spectrum or spectrums to determine a deconvolved elemental composition of the test sample. | 02-23-2012 |